“…Furthermore, in this study, CA-4P inhibited sprout formation at concentrations that did not inhibit the proliferation of endothelial cells, confirming direct antiangiogenic properties of CA-4P. Similarly, modulation of endothelial cells by combretastatin analogs has been reported in vitro (Dupeyre et al, 2006;Kong et al, 2010;Romagnoli et al, 2010;Sanna et al, 2010;Arthuis et al, 2011;Porcù et al, 2013) and in vivo (Fortin et al, 2011;Porcù et al, 2013;Zheng et al, 2014). The molecular mechanism of the antiangiogenic properties of TR-644 CA-4 analog was linked to the inhibition of vascular endothelial growth factor-induced phosphorylation of VE-cadherin (Porcù et al, 2013).…”